Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
myTomorrows General Information
myTomorrows operates a global digital health platform that has matched over 15,000 patients to clinical trials or expanded access programs using AI-driven technology. The company partners with biopharma for patient recruitment and real-world data collection but does not develop its own therapeutics.[5][8]
Contact Information
Website
Primary Industry
Biomedical IT and Biomedical Data Platforms
Corporate Office
Amsterdam,
Netherlands
Netherlands
Drug Pipeline
No pipeline data available
Key Partnerships
Scout Clinical (for cross-border trial access)[5], Patient advocacy groups such as The ALS Association, Pancreatic Cancer Europe, CureLGMD2i[5]
myTomorrows Funding
No funding data available
To view myTomorrows's complete valuation and funding history, request access »